HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Design and synthesis of new mitochondrial cytotoxin N-thiadiazolylanilines that inhibit tumor cell growth.

Abstract
New N-thiadiazolylanilines were designed and synthesized to develop mitochondrial cytotoxins superior to SF 6847. The mitochondrial cytotoxin N-thiadiazolylanilines, TX-108 and TX-109, inhibited EMT6/KU mammary sarcoma cell growth at a low micromolar concentration. Their inhibitory activities were parallel to their mitochondrial cytotoxicity, such as uncoupling oxidative phosphorylation and inhibiting ATP synthesis. This report also supports the notion that the inhibition of tumor cell growth of inhibitor of protein tyrosine kinase AG17, which is identical to SF 6847, may be due to its mitochondrial cytotoxicity.
AuthorsH Hori, N Noguchi, H Yokoyama, H Ise, C Z Jin, S Kasai, T Goto, Z Taira
JournalBioorganic & medicinal chemistry (Bioorg Med Chem) Vol. 4 Issue 2 Pg. 247-53 (Feb 1996) ISSN: 0968-0896 [Print] ENGLAND
PMID8814882 (Publication Type: Journal Article)
Chemical References
  • Aniline Compounds
  • Antineoplastic Agents
  • Cytotoxins
  • Nitriles
  • TX 108
  • TX 109
  • Thiadiazoles
  • Uncoupling Agents
  • SF 6847
  • Adenosine Triphosphate
  • Protein-Tyrosine Kinases
Topics
  • Adenosine Triphosphate (biosynthesis)
  • Aniline Compounds (chemical synthesis, chemistry, metabolism, pharmacology)
  • Animals
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Cell Division (drug effects)
  • Cytotoxins (chemical synthesis, pharmacology)
  • Drug Design
  • Male
  • Mammary Neoplasms, Experimental (enzymology, pathology)
  • Mitochondria (drug effects, metabolism)
  • Nitriles (pharmacology)
  • Protein-Tyrosine Kinases (antagonists & inhibitors)
  • Rats
  • Rats, Wistar
  • Sarcoma, Experimental (enzymology, pathology)
  • Thiadiazoles (chemical synthesis, pharmacology)
  • Tumor Cells, Cultured
  • Uncoupling Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: